Security key
69012T305
Outlook Therapeutics, Inc. - Common Stock, par value $0.01 per share (OTLK)
CUSIP: 69012T305
Q1 2024 13F Holders as of 31 Mar 2024
- Security type / class
- Equity / Common Stock, par value $0.01 per share
- Total 13F shares
- 7,236,418
- Total 13F value
- $86,189,121
- Share change
- +7,197,719
- SEC-reported price per share
- $11.94
- Number of holders
- 53
- Value change
- +$86,127,774
- Number of buys
- 52
- Number of sells
- 1
- Shares outstanding
- 164,107,590
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2024
Institutions
53
Top holders
10
OTLK full security history
Ownership snapshot
Full 13F holder table
Outlook Therapeutics, Inc. SEC filings
Outlook Therapeutics, Inc. company facts
Broader feeds
Ownership snapshot
Top reported holders of OTLK - Outlook Therapeutics, Inc. - Common Stock, par value $0.01 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Arun Kumar Pillai
Disclosed value leader
Arun Kumar Pillai
Comparable rows
0/15
Latest evidence
20 Mar 2024
3/4/5
13F
Highest disclosed value: $26,085,170
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
Arun Kumar Pillai has the largest disclosed position value at $26.09M.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Arun Kumar Pillai's linked filing trail.
Disclosed position value
Top 5
Arun Kumar Pillai
$26.09M
Tenshi Healthcare Pte. Ltd.
$26.09M
BlackRock Finance, Inc.
$4.08M
VANGUARD GROUP INC
$2.58M
GEODE CAPITAL MANAGEMENT, LLC
$1.17M
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Arun Kumar Pillai |
3/4/5
Director, 10%+ Owner
|
—
class O/S missing
|
$26,085,170
22,982,529 shares
|
— | 01 Feb 2022 |
| Tenshi Healthcare Pte. Ltd. |
3/4/5
10%+ Owner
|
—
class O/S missing
|
$26,085,170
22,982,529 shares
|
— | 21 Apr 2022 |
| BlackRock Finance, Inc. |
13F
Company
|
—
class O/S missing
|
$4,084,316
10,366,285 shares
|
— | 31 Dec 2023 |
| VANGUARD GROUP INC |
13F
Company
|
—
class O/S missing
|
$2,584,798
6,560,400 shares
|
— | 31 Dec 2023 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
—
class O/S missing
|
$1,170,430
2,970,346 shares
|
— | 31 Dec 2023 |
| STATE STREET CORP |
13F
Company
|
—
class O/S missing
|
$1,113,638
2,826,493 shares
|
— | 31 Dec 2023 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
53
Shares
7,236,418
Rows available
53
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2024 vs Q1 2024 Across Filers
Q1 2024 holders
53
Q1 2024 holders
53
Holder diff
0
| Investor | Q1 2024 Shares | Q1 2024 Shares | Share Diff | Share Chg % | Q1 2024 value | Q1 2024 value | Value change | Value Chg % |
|---|